FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

New CDRH Web Page on Diagnostic Data Program

CDRH launches a new Web page to discuss mission-critical priorities of data and technology innovations and provide information and resources on its Di...

latest-news-card-1
Medical Devices

Getinge PMA Approved for Iliac Artery Stent

FDA approves a Getinge PMA for its iCast covered stent system for treating patients with iliac arterial occlusive disease.

latest-news-card-1
Human Drugs

Dose Optimization Info for Combo Drugs Needed: PhRMA

Pharmaceutical Research and Manufacturers of America says a recent FDA draft guidance on oncologic drug development provides limited information on ho...

latest-news-card-1
Human Drugs

Incyte Complete Response on Once-daily Jakafi

FDA issues Incyte a complete response letter for Jakafi (ruxolitinib) extended-release tablets, a JAK1/JAK2 inhibitor for once-daily use in treating c...

latest-news-card-1
Human Drugs

Panel Backs Accelerated OK Consideration of Biogen's ALS Drug

An FDA advisory committee votes 9 to 0 that Biogens amyotrophic lateral sclerosis drug tofersen should be considered for accelerated approval.

latest-news-card-1

FDA Digital Health Technologies Framework

As required by the PDUFA 7 agreement, FDA publishes a framework for how it will implement a multifaceted program for using digital health technologies...

latest-news-card-1
Medical Devices

Xtrava Covid Test Less Effective with Some Variants: FDA

FDA adds the Xtrava Health SPERA Covid-19 test to the list of tests expected to have a reduced performance with certain Covid-19 Omicron sub-variants.

latest-news-card-1
Medical Devices

Unibody Endografts Dont Beat Older Ones: Study

FDA-funded research finds that unibody endografts are not non-inferior to non-unibody devices, leading to updated FDA labeling.

latest-news-card-1
Medical Devices

FDA Reminds on Recalled Exactech Joint Devices

FDA reminds patients and healthcare providers about risks associated with recalled Exactech replacement joint devices that were packaged in defective ...

latest-news-card-1
Human Drugs

Dupixent Meets Key Phase 3 Endpoints: Regeneron

Regeneron and Sanofi say an investigational Phase 3 trial of Dupixent in some COPD patients met all key primary and secondary endpoints.